Prenatal origin of separate evolution of leukemia in identical twins

Leukemia

Volumn 18, Issue 10, 2004, Pages 1624-1629

  Teuffel, O ^a   Betts, D R ^a   Dettling, M ^b   Schaub, R ^a   Schafer B W ^a   Niggli, Felix K ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

ALL; Gene expression profiling; Immunoglobulin gene rearrangements; Monozygotic twins; TEL AML1

Indexed keywords

GENOMIC DNA; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ARTICLE; BLOOD ANALYSIS; CHILDHOOD LEUKEMIA; CHROMOSOME ABERRATION; CLINICAL FEATURE; CLINICAL OBSERVATION; CONTROLLED STUDY; DIAGNOSTIC TEST; DNA MICROARRAY; FUSION GENE; GENE EXPRESSION PROFILING; GENE INDUCTION; GENE REARRANGEMENT; GENE SEQUENCE; GENETIC CONSERVATION; GENETIC IDENTIFICATION; GENETIC TRAIT; HUMAN; IMMUNOGLOBULIN GENE; LEUKEMOGENESIS; MOLECULAR CLONING; MONOZYGOTIC TWINS; NEWBORN; NUCLEOTIDE SEQUENCE; PRELEUKEMIA; PRENATAL PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 6344285984     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403462     Document Type: Article

References (30)

1. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 1995; 92: 4917-4921.
2. Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R et al. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 1995; 85: 3662-3670.
3. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML et al. TEL/AML1 fusion resulting from a cryptic t(12; 21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985-1989.
4. Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig WD, Burci L et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Munster Study Group. Blood 1997; 90: 571-577.
5. Ford AM, Bennett CA, Price CM, Bruin MC, Van Wering ER, Greaves M. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci USA 1998; 95: 4584-4588.
6. Wiemels JL, Ford AM, Van Wering ER, Postma A, Greaves M. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood 1999; 94: 1057-1062.
7. Wiemels JL, Cazzaniga G, Daniotti M, Eden OB, Addison GM, Masera G et al. Prenatal origin of acute lymphoblastic eukaemia in children. Lancet 1999; 354: 1499-1503.
8. Maia AT, Ford AM, Jalali GR, Harrison CJ, Taylor GM, Eden OB et al. Molecular tracking of leukemogenesis in a triplet pregnancy. Blood 2001; 98: 478-482.
9. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood 2003; 102: 2321-2333.
10. Greaves MF. Aetiology of acute leukaemia. Lancet 1997; 349: 344-349.
11. Andreasson P, Schwaller J, Anastasiadou E, Aster J, Gilliland DG. The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. Cancer Genet Cytogenet 2001; 130: 93-104.
12. Bernardin F, Yang Y, Cleaves R, Zahurak M, Cheng L, Civin CI et al. TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. Cancer Res 2002; 62 3904-3908.
13. Raynaud S, Cave H, Baens M, Bastard C, Cacheux V, Grosgeorge J et al. The 12;21 translocation involving TEL and deletion of the other TEL allele: two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 1996; 87: 2891-2899.
14. Raynaud SD, Dastugue N, Zoccola D, Shurtleff SA, Mathew S, Raimondi SC. Cytogenetic abnormalities associated with the t(12;21): a collaborative study of 169 children with t(12;21)-positive acute lymphoblastic leukemia. Leukemia 1999; 13: 1325-1330.
15. Fasching K, Panzer S, Haas OA, Marschalek R, Gadner H, Panzer-Grumayer ER. Presence of clone-specific antigen receptor gene rearrangements at birth indicates an in utero origin of diverse types of early childhood acute lymphoblastic leukemia. Blood 2000; 95: 2722-2724.
16. Yagi T, Hibi S, Tabata Y, Kuriyama K, Teramura T, Hashicla T et al. Detection of clonotypic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia. Blood 2000; 96: 264-268.
17. Taub JW, Konrad MA, Ge Y, Naber JM, Scott JS, Matherly LH et al. High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. Blood 2002; 99: 2992-2996.
18. Maia AT, Tussiwand R, Cazzaniga G, Rebulla P, Colman S, Biondi A et al. Identification of preleukemic precursors of hyperdiploid acute lymphoblastic leukemia in cord blood. Genes Chromosomes Cancer 2004; 40: 38-43.
19. Teuffel O, Dettling M, Cario G, Stanulla M, Schrappe M, Bühlmann P et al. Association of gene expression profiles with risk stratification in childhood acute lymphoblastic leukemia. Haematologica 2004; 89: 801-808.
20. McHale CM, Wiemels JL, Zhang L, Ma X, Buffler PA, Guo W et al. Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California. Genes Chromosomes Cancer 2003; 37: 36-43.
21. Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuijs AJ, Jacobs DC, Joosten SA et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia 2000; 14: 1426-1435.
22. van der Velden VH, Willemse MJ, van der Schoot CE, Hahlen K, van Wering ER, van Dongen JJ. Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR. Leukemia 2002; 16: 928-936.
23. Pongers-Willemse MJ, Seriu T, Stolz F, d'Aniello E, Gameiro P, Pisa P et al. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13 110-118.
24. Peham M, Konrad M, Harbott J, Konig M, Haas OA, Panzer-Grumayer ER. Clonal variation of the immunogenotype in relapsed ETV6/RUNX1 -positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development. Genes Chromosomes Cancer 2004; 39: 156-160.
25. Pine SR, Wiemels JL, Jayabose S, Sandoval C. TEL-AML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia. Leuk Res 2003; 27: 155-164.
26. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531-537.
27. Ferrando AA, Neuberg IDS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.
28. Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41-47.
29. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133-143.
30. Greaves M. Molecular genetics, natural history and the demise of childhood leukaemia. Eur J Cancer 1999; 35: 1941-1953.